Macromoltek
YC W18Austin, US · Founded 2010 · 14 employees · 2 known investors
Macromoltek provides computational modeling and AI-driven antibody design services to biotech and pharmaceutical companies, accelerating the discovery and optimization of therapeutic antibodies. The platform reduces time-to-market and increases the probability of clinical success in drug development.
AI & Machine LearningBiotechHealthtechAI-powered Drug DiscoveryDeep LearningTherapeuticsin /macromoltek-inc/@macromoltek
Founders & leadership· Y Combinator alumni (W18)
Susana KaufmanninCTO
Investors · 2
In the news
- Macromoltek - 2026 Company Profile, Team, Funding & Competitors - Tracxntracxn.com · 2021
- Macromoltek - 2026 Funding Rounds & List of Investors - Tracxntracxn.com · 2021